Clinical trial · Observational
Registry of Pancreatic Disease
Registry of Subjects Affected by Pancreatic Disease and Evaluated at the Pancreas Institute of Verona
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Diseases | — | UNRESOLVED | — |
| Pancreatic Neoplasms | Pancreatic Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Pancreatitis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Patient with pancreatic disease
- description
- Patients diagnosed with pancreatic disease evaluated at this institution.
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 1 year
- description
- Survival from Diagnosis to time of death
Secondary outcomes (1)
- measure
- Postoperative morbidity
- timeFrame
- 90 days
- description
- Occurrence of Pancreatic Fistula, Biliary fistula, Enteric fistula, Delayed Gastric Emptying, Hemorrhage or Sepsis.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions) Exclusion Criteria: * physically or mentally inability to provide consent
References
Publications (0)
Data not yet available